IAM
PRTK

ICM Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

ICM Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$846K Buy
156,300
+3,400
+2% +$16.8K 4.67% 11
2020
Q2 		$798K Sell
152,900
-294,915
-66% -$1.31M 4.2% 11
2020
Q1 		$1.41M Sell
447,815
-500
-0.1% -$1.84K 1.38% 13
2019
Q4 		$1.81M Buy
448,315
+163,000
+57% +$565K 1.48% 18
2019
Q3 		$1.23M Buy
+285,315
New +$1.14M 0.95% 25

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ICM Asset Management's PRTK Position: Q3 2020 in Review

ICM Asset Management increased its Paratek Pharmaceuticals, Inc. (PRTK) stake by 2.2% in Q3 2020, buying an estimated $16.8K and bringing the position to 156,300 shares worth $846K. The position accounts for 4.67% of the portfolio, ranked #11.

ICM Asset Management first reported a position in PRTK in Q3 2019 and has held it in 5 quarters since. The position peaked at $1.81M in Q4 2019. 100 funds tracked by Wall St. Rank hold PRTK as of Q3 2020.

  • ICM Asset Management held 156,300 shares of Paratek Pharmaceuticals, Inc. worth $846K as of Q3 2020.
  • ICM Asset Management bought 3,400 Paratek Pharmaceuticals, Inc. shares in Q3 2020, an estimated $16.8K.
  • Paratek Pharmaceuticals, Inc. made up 4.67% of ICM Asset Management's portfolio in Q3 2020, its #11 holding.
  • ICM Asset Management first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2019 and has held it in 5 quarters since.
  • ICM Asset Management's Paratek Pharmaceuticals, Inc. position peaked at $1.81M in Q4 2019.
  • 100 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2020.

Based on ICM Asset Management's 13F filing for Q3 2020, filed 22 Oct 2020.